Clinical Pharmacology of Muscle Relaxants in Patients With Burns

The Journal of Clinical Pharmacology

Volumn 26, Issue 8, 1986, Pages 680-685

  Martyn, Jeevendra ^a   Goldhill, David R ^a   Goudsouzian, Nishan G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CHOLINERGIC RECEPTOR; DIMETHYLTUBOCURARINE CHLORIDE; MUSCLE RELAXANT AGENT; PANCURONIUM; SUXAMETHONIUM; TUBOCURARINE CHLORIDE; VECURONIUM;

ANESTHESIA; BURN; DRUG THERAPY; HUMAN; INJURY; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE; NEUROMUSCULAR BLOCKING; PERIPHERAL NERVOUS SYSTEM; PHARMACOKINETICS; PHARMACOLOGY; PRIORITY JOURNAL; REVIEW; THERAPY;

BURNS; HUMAN; MUSCLE RELAXANTS, CENTRAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SUCCINYLCHOLINE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022970017     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1986.tb02972.x     Document Type: Article

References (59)

1. Pathophysiology and management of burn trauma in children
2. Medical progress: Burns
3. Burns
4. Microvascular fluid and protein flux in pulmonary and systemic circulations after thermal injury
5. Effect of injury and infection on visceral metabolism and circulation
6. Diazepam kinetics in patients with severe burns
7. Lorazepam conjugation unpaired in burned patients
8. Increased cimetidine clearance in burn patients
9. Drug kinetics in burn patients
10. Physiologic response to crystalloid resuscitation of severe burns
11. Fentanyl‐oxygen anesthesia for coronary artery surgery: Cardiovascular and antidiuretic hormone responses
12. Cardiovascular responses to large doses of intravenous morphine in man
13. Monitoring of neuromuscular function
14. Improved oxygenation after muscle relaxation in adult respiratory distress syndrome
15. Pancuronium during mechanical ventilation speeds recovery of lungs of infants with hyaline membrane disease
16. The effects of pancuronium in infants with hyaline membrane disease
17. Hemodynamic and gas exchange effects of pancuronium bromide in sedated patients with respiration failure
18. Suxanethonium
19. Serum cholinesterase activity in burned patients
20. Pathophysiology of hyperkalemia induced by succinylcholine
21. Succinylcholine‐induced hyperkalemia in burned patients‐2
22. Succinylcholine‐induced hyperkalemia in burned patients‐1
23. Ventricular fibrillation in a burned boy
24. Succinylcholine danger in the burned patient
25. Electrical injury simulates crush injury
26. Two factors responsible for the development of denervation hypersensitivity
27. Exaggerated increase in serum potassium following succinylcholine in dogs with beta blockage
28. Impairment of extrarenal potassium disposal by α‐adrenergic stimulation
29. Verapamil versus rate of development and hemodynamic effects of acute hyperkalemia in halothane‐anesthetized dogs: Effect of calcium therapy
30. Succinylcholine, cholinoceptors and proposed mechanism of early adverse hemodynamic reaction
31. A comparative evaluation of pretreatment with non‐depolarizing neuromuscular blockers prior to administration of succinylcholine
32. Does diazepam pretreatment prevent succinylcholine induced fasiculations? A double blind comparison of diazepam and d‐tubocurarine pretreatment
33. Unprecedented resistance to neuromuscular blocking effect of metocurine with persistence after complete recovery in a burned patient
34. A possible mechanism for succinylcholine hyperkalemia (letter)
35. Control of acetylcholine receptors in skeletal muscle
36. Alterations in cat skeletal muscle neuromuscular junctions following prolonged inactivity
37. Resistance to nondepolarizing muscle relaxants in paretic upper extremities of patients with residual hemiplegia
38. Increased d‐tubocurarine requirements following thermal injury
39. Metocurine requirements in burned patients: Relation of plasma concentration to neuromuscular blockade
40. Neuromuscular effects of pancuronium in burned children
41. The use of muscle relaxants in burnt children
42. Peripheral polyneuropathy among patients with burns
43. Perpheral neurologic problems in the acute burn patient
44. Depressed reflex vasomotor control of the burn wound
45. Effect of succinylcholine or skeletal muscle with immobilization atrophy
46. Evaluation of atracurium neuromuscular blockade in patients with thermal injury (abstract)
47. Potentiation of neuromuscular blockade with pancuronium and dimethyltubocurarine combination
48. Burn patients are resistant to atracurium (abstract)
49. Plasma protein binding of drugs after severe burn injury
50. Elevated plasma binding cannot account for the burn related d‐tubocurarine hyposensitivity
51. Pharmacokinetics. of d‐tubocurarine in patients with burns
52. A sheet preparation for studying interactions between blood flow and drug disposition. The effects of general and spinal anaesthesia on blood flow and cefitoxin disposition
53. Clinical pharmacokinetics
54. Pharmacology of muscle relaxants, their agonists and monitoring of neuromuscular function
55. Pharmacokinetics of pentobarbital, quinidine, lidocaine and theophylline in the thermally injured rat
56. Cardiovascular and neuromuscular responses to high dose pancuronium‐metocurine combination
57. Clinical pharmacology of vecuronium and atracurium
58. Renal and biliary elimination of vecuronium Org NC4J and pancuronium in rats
59. The priming principle